Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Jun 13, 2022

50715_rns_2022-06-13_b759c870-6eef-4e19-8066-49802a880bf3.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

13 June 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Description
of relevant
securities
Description
of products
Nature of
dealings
Number of
reference
securities to
which the
derivatives
relate
Maturity
date /
closing out
date
Reference
price
Total amount
paid / received
Resultant
balance
(including
those of any
person with
whom there is
an agreement
or
understanding)
China
International
Capital
Corporation
Limited
10 June 2022 Derivatives Other types of
products
Closing out of a
derivative contract
4,000 19 February
2025
$28.2000 $112,800.0000 74,000
Derivatives Other types of
products
Closing out of a
derivative contract
6,000 22 May 2024 $28.2000 $169,200.0000 58,000
Derivatives Other types of
products
Closing out of a
derivative contract
4,000 19 February
2025
$28.2000 $112,800.0000 74,000

==> picture [71 x 43] intentionally omitted <==

Public Disclosure Form

Derivatives Other types of
products
Closing out of a
derivative contract
6,000 22 May 2024 $28.2000 $169,200.0000 58,000

End

Note:

China International Capital Corporation Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.